GE Healthcare & Hansen Medical Announce Collaboration to Promote Use of Fluoroscopic Imaging System

649

GE Healthcare and Hansen Medical, Inc. announced that they have entered into a collaboration to promote the use of GE Healthcare's imaging technologies and Hansen Medical's robotic catheter technologies for electrophysiology (EP) procedures. In addition, the companies expect to pursue integrated product offerings in connection with their collaboration. 

The partnership enables the companies to promote the compatibility of the GE Innova X-ray imaging platform with Hansen Medical's Sensei(R) Robotic Catheter System. The companies seek to further augment the capabilities of electrophysiologists to perform EP procedures.

"GE Healthcare is committed to the success of leading technologies including the Hansen flexible robotics platform," said Jayant Saha, general manager, Interventional Marketing, GE Healthcare. "We are committed to improving the clinical experience of the electrophysiologist and see this strategic collaboration as a key component of reaching that goal. We believe that this partnership is a key strategic choice for our imaging and electrophysiology businesses."

"We strongly believe in the synergistic importance of integrating imaging and robotics technology and have entered into this collaboration to bring this clinical value to our electrophysiologists and their patients," said Frederic Moll, M.D., CEO of Hansen Medical. "We are pleased to collaborate with GE Healthcare, a global leader in medical imaging, in this important collaboration."

The Sensei system allows physicians to instinctively position robotic catheters in difficult anatomical locations within the heart in a stable and controlled manner.

The GE Healthcare Innova imaging system affords clinicians the opportunity to perform angiographic studies efficiently, accurately and reliably during EP and interventional procedures.

About Hansen Medical, Inc.

Hansen Medical, Inc., based in Mountain View, Calif., develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei Robotic Catheter system, is a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability during complex cardiac arrhythmia procedures. The Sensei system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data and was cleared by the U.S. Food and Drug Administration (FDA) in May 2007 for manipulation and control of certain mapping catheters in Electrophysiology (EP) procedures. The safety and effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established. The Sensei system is CE Marked for use during EP procedures, such as guiding catheters in the treatment of AF. Additional information can be found at www.hansenmedical.com.

GE Healthcare Media Contact:

Autumn Latimore
T: 414.721.4013
C: 262.497.2753